|Articles|October 1, 2012
- Pharmaceutical Executive-10-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2012
Lundbeck's Big Bet
Advertisement
Articles in this issue
about 13 years ago
PE, October 2012 Cover Imageabout 13 years ago
Lundbeck: Bidding for the Stars and Stripesabout 13 years ago
The Drug Vote 2012about 13 years ago
Your Local Competitor: A Threat in Emerging Markets?about 13 years ago
Reforming Pharma Marketingabout 13 years ago
Three Ways to the Futureabout 13 years ago
Country Report: Turkeyabout 13 years ago
Stem Cells: A Promise Deferred?about 13 years ago
Richard Bergström — Europe's Medicine ManNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina
2
Pharmaceutical Executive Daily: Most Favored Nation Order's Evolving Landscape
3
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
4
AstraZeneca to Announce Deal with Trump Administration: Report
5
